Medical education, not medical advice. This guide does not diagnose, treat, or replace professional care, and no product listed is endorsed or matched to your individual microbiome.
The Good Bacteria Guide
"I'd like to order some bacteria, please."
Oral probiotics, decoded. Which strains, which brands, and what the science actually says.
Your mouth isn't supposed to be sterile. Researchers are exploring whether adding specific beneficial bacteria can support a healthier oral ecosystem. But the strain matters, and the science is still developing.
Section 01
What Are Oral Probiotics?
Oral probiotics are products containing live microorganisms intended to provide a health benefit when administered in adequate amounts. Products designed for the oral environment may come as lozenges, dissolving tablets, chewables, or drops. Researchers study them for gingival inflammation, breath odor, plaque ecology, caries-associated microorganisms, and throat health. Outcomes vary by strain and formulation.
New to the oral microbiome? Start with our bacteria catalog, which covers both the beneficial and the pathogenic residents of your mouth.
Section 02
How Do They Work?
Competitive exclusion
Beneficial bacteria can occupy attachment sites on tooth and tissue surfaces, making it harder for less desirable organisms to settle in the same ecological niches.
Competition for nutrients and sites
Strains compete for the sugars and binding sites other bacteria need, which can shift the balance of the local ecosystem.
Antimicrobial compounds
Some strains produce substances such as bacteriocins that inhibit the growth of other bacteria in laboratory settings.
Possible immune interactions
Researchers are also studying whether certain strains interact with local immune responses in the mouth.
Taking a probiotic does not guarantee permanent colonization, or any clinical benefit. Detected changes are usually temporary and depend on continued use and the specifics of each strain.
Section 03
Explore the Strains
Every strain below is identified by its species and its exact strain ID. Tap a card to see its research focus, example product, and evidence limitations.
Research focus
Periodontal and gingival research
Example product
BioGaia Prodentis
Evidence limitations
Studied mainly as an adjunct to standard periodontal care, not as a standalone treatment. Effects on bleeding and gingival inflammation have been reported in clinical trials, but outcomes vary by study design and population.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Throat and breath research
Example product
BLIS K12 (BLIS Probiotics)
Evidence limitations
Research has explored throat microbiome ecology and volatile sulfur compounds associated with breath odor. Evidence for breath outcomes is mixed across studies, and persistent breath changes warrant a professional evaluation.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Plaque ecology and caries-associated bacteria
Example product
BLIS M18 (BLIS Probiotics)
Evidence limitations
Laboratory and early clinical work describes effects on plaque-associated bacteria. Long-term evidence that this strain prevents cavities remains limited. Microbial shifts do not establish cavity prevention.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Microbial competition (colonization resistance)
Example product
ProBiora3 blend (ProBioraHealth)
Evidence limitations
Studied for its ability to compete with odor- and caries-associated bacteria in the oral environment. Much of the supporting work is laboratory research; human clinical outcome data are more limited.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Microbial competition (colonization resistance)
Example product
ProBiora3 blend (ProBioraHealth)
Evidence limitations
Part of a three-strain blend studied for competition with cariogenic organisms. Blend-level results cannot be attributed to this strain alone.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Competition with cariogenic organisms
Example product
ProBiora3 blend (ProBioraHealth)
Evidence limitations
Investigated for occupying ecological niches used by caries-associated bacteria. Human cavity-prevention evidence remains limited.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Halitosis and volatile sulfur compounds
Example product
Emerging South Korean probiotic ingredient (no verified commercial listing yet)
Evidence limitations
An active research area, primarily from South Korean academic groups. We will list a commercial product only after a current product and its label have been verified.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Research focus
Plaque and caries-related research (strain-specific)
Example product
Various (evidence varies by specific strain)
Evidence limitations
Evidence is strain-specific. Findings from one L. paracasei strain must not be generalized to products that list the species without the exact strain identifier.
Clinical citations
Clinical citations pending validation. We display references only after verifying the study and its link.
Section 04
Global Product Directory
Educational listing, not endorsement. We list what each manufacturer says is in the product, and we flag anything we have not verified. Cards are text-only unless official manufacturer photography is available.
"Verification pending" means the exact strain identifiers or current formulation have not been confirmed from the manufacturer's current label. Treat those details as unconfirmed until the badge changes.
BLIS K12
New Zealand
- Strains
- Streptococcus salivarius K12
- Research focus
- Throat health and breath research
BLIS M18
New Zealand
- Strains
- Streptococcus salivarius M18
- Research focus
- Plaque ecology and caries-associated bacteria
BURST Oral Probiotics
USA
- Strains
- Verification pending: confirm current formulation from manufacturer before displaying strain details.
- Research focus
- General oral microbiome support
BioGaia Prodentis
Sweden
- Strains
- L. reuteri DSM 17938 + L. reuteri ATCC PTA 5289
- Research focus
- Gingival inflammation and periodontal health (adjunct to professional care)
Hyperbiotics PRO-Dental
USA
- Strains
- Verification pending: confirm current formulation from manufacturer before displaying strain details.
- Research focus
- General oral microbiome support
NOW OralBiotic
USA
- Strains
- S. salivarius K12 (per historical label; verify current label before displaying)
- Research focus
- Throat health and breath research
ProBiora
USA
- Strains
- ProBiora3 blend: S. oralis KJ3, S. uberis KJ2, S. rattus JH145
- Research focus
- Microbial competition with odor- and caries-associated bacteria
SuperTeeth Dental Probiotic
USA
- Strains
- Multi-strain formula. Exact current strain identifiers are verification pending with the manufacturer.
- Research focus
- General oral microbiome support (multi-strain)
Section 05
Find Your Research Starting Point
What are you hoping to support?
Select an area above to see which strains researchers have studied and what the evidence does and does not show.
Section 06
How to Read the Label
Species versus exact strain ID
Lactobacillus reuteri is a species. L. reuteri DSM 17938 is a specific strain. Most published research is tied to the strain, not the species, so a product that lists only the species cannot be matched to that evidence. Look for the full strain identifier on the label.
CFU counts
CFU (colony-forming units) describes how many live microorganisms a serving contains. Higher counts are not automatically better. The doses studied in research vary by strain and outcome, and more is not the same as more effective.
Lozenges versus chewables versus drops
Oral probiotics are formulated to spend time in contact with the mouth: lozenges that dissolve slowly, chewables, and drops or powders. The intended benefit is local, which is why many are not swallowed immediately like gut probiotics.
Human clinical evidence versus laboratory studies
A strain that inhibits another bacterium in a petri dish has not necessarily shown a health benefit in people. Human clinical trials are a higher standard of evidence than laboratory research, and many products rely mainly on laboratory data.
Bacterial markers versus clinical outcomes
A study may show that a product changes which bacteria are detectable in plaque or saliva. That is a microbial marker, not a clinical outcome. Reduced bleeding, fewer cavities, or improved breath are the outcomes that matter, and they require separate evidence.
Section 07
What Does the Science Say?
Periodontal health
Promising adjunctive evidence for selected strains
Clinical trials of Lactobacillus reuteri DSM 17938 and ATCC PTA 5289, used alongside standard periodontal care, have reported improvements in gingival inflammation and bleeding compared with care alone in some studies. Findings vary, and no oral probiotic is a substitute for professional periodontal evaluation and treatment.
Halitosis (breath odor)
Mixed and strain-specific evidence
Strains including Streptococcus salivarius K12 and Weissella cibaria CMU have been investigated for reducing volatile sulfur compounds associated with breath odor. Results across studies are mixed, and the effect appears strain-specific. Persistent breath concerns should be evaluated professionally, since causes extend beyond the oral microbiome.
Caries prevention (cavities)
Microbial effects studied; long-term prevention evidence remains limited
Strains such as Streptococcus salivarius M18 and the ProBiora3 blend organisms have been studied for effects on caries-associated bacteria in plaque. Long-term clinical evidence that any oral probiotic prevents cavities remains limited. Fluoride, diet, plaque removal, and professional care remain the established approaches.
Last reviewed: 2026-10-26. We publish a reference only after validating the study and its link, so the citation fields in this guide are currently being verified rather than filled with unconfirmed references.
For our broader, citation-backed library, see the Research & Evidence hub.
Section 08
Frequently Asked Questions
Safety note: people who are significantly immunocompromised or medically vulnerable should consult their physician before using any product containing live microorganisms.
Medical education disclaimer: The Good Bacteria Guide is general health education, not medical advice, diagnosis, or treatment. It does not replace evaluation by a dentist, physician, or other qualified professional. Probiotic products are not medications, and no listing on this page is an endorsement, a prescription, or a match to your individual microbiome. If you are significantly immunocompromised or medically vulnerable, speak with your physician before using any live- microorganism product.
